vs

Side-by-side financial comparison of CARTERS INC (CRI) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.

CARTERS INC is the larger business by last-quarter revenue ($757.8M vs $384.8M, roughly 2.0× P3 Health Partners Inc.). CARTERS INC runs the higher net margin — 1.5% vs -19.6%, a 21.2% gap on every dollar of revenue. On growth, P3 Health Partners Inc. posted the faster year-over-year revenue change (3.8% vs -0.1%).

Carter's, Inc. is a major American designer and marketer of children's apparel. It was founded in 1865 by William Carter.

P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.

CRI vs PIII — Head-to-Head

Bigger by revenue
CRI
CRI
2.0× larger
CRI
$757.8M
$384.8M
PIII
Growing faster (revenue YoY)
PIII
PIII
+3.9% gap
PIII
3.8%
-0.1%
CRI
Higher net margin
CRI
CRI
21.2% more per $
CRI
1.5%
-19.6%
PIII

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CRI
CRI
PIII
PIII
Revenue
$757.8M
$384.8M
Net Profit
$11.6M
$-75.5M
Gross Margin
45.1%
Operating Margin
3.8%
-40.0%
Net Margin
1.5%
-19.6%
Revenue YoY
-0.1%
3.8%
Net Profit YoY
-80.1%
-28.8%
EPS (diluted)
$0.32
$-23.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRI
CRI
PIII
PIII
Q4 25
$384.8M
Q3 25
$757.8M
$345.3M
Q2 25
$585.3M
$355.8M
Q1 25
$629.8M
$373.2M
Q4 24
$370.7M
Q3 24
$362.1M
Q2 24
$379.2M
Q1 24
$388.5M
Net Profit
CRI
CRI
PIII
PIII
Q4 25
$-75.5M
Q3 25
$11.6M
$-31.6M
Q2 25
$446.0K
$-20.4M
Q1 25
$15.5M
$-20.5M
Q4 24
$-58.6M
Q3 24
$-46.5M
Q2 24
$-12.0M
Q1 24
$-18.7M
Gross Margin
CRI
CRI
PIII
PIII
Q4 25
Q3 25
45.1%
Q2 25
48.1%
Q1 25
46.2%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
CRI
CRI
PIII
PIII
Q4 25
-40.0%
Q3 25
3.8%
-12.8%
Q2 25
0.7%
-9.6%
Q1 25
4.1%
-10.2%
Q4 24
-37.4%
Q3 24
-29.5%
Q2 24
-8.3%
Q1 24
-11.3%
Net Margin
CRI
CRI
PIII
PIII
Q4 25
-19.6%
Q3 25
1.5%
-9.1%
Q2 25
0.1%
-5.7%
Q1 25
2.5%
-5.5%
Q4 24
-15.8%
Q3 24
-12.8%
Q2 24
-3.2%
Q1 24
-4.8%
EPS (diluted)
CRI
CRI
PIII
PIII
Q4 25
$-23.08
Q3 25
$0.32
$-9.67
Q2 25
$0.01
$-6.23
Q1 25
$0.43
$-6.28
Q4 24
$-23.13
Q3 24
$-15.70
Q2 24
$-7.37
Q1 24
$-7.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRI
CRI
PIII
PIII
Cash + ST InvestmentsLiquidity on hand
$184.2M
$25.0M
Total DebtLower is stronger
$228.4M
Stockholders' EquityBook value
$864.6M
$-155.2M
Total Assets
$2.5B
$656.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRI
CRI
PIII
PIII
Q4 25
$25.0M
Q3 25
$184.2M
$37.7M
Q2 25
$338.2M
$38.6M
Q1 25
$320.8M
$40.1M
Q4 24
$38.8M
Q3 24
$63.0M
Q2 24
$73.1M
Q1 24
$27.3M
Total Debt
CRI
CRI
PIII
PIII
Q4 25
$228.4M
Q3 25
$252.8M
Q2 25
$182.0M
Q1 25
$171.1M
Q4 24
$108.9M
Q3 24
$133.2M
Q2 24
$133.1M
Q1 24
$118.1M
Stockholders' Equity
CRI
CRI
PIII
PIII
Q4 25
$-155.2M
Q3 25
$864.6M
$-18.7M
Q2 25
$853.9M
$44.5M
Q1 25
$847.2M
$63.3M
Q4 24
$75.9M
Q3 24
$120.5M
Q2 24
$166.8M
Q1 24
$146.6M
Total Assets
CRI
CRI
PIII
PIII
Q4 25
$656.6M
Q3 25
$2.5B
$683.6M
Q2 25
$2.5B
$731.6M
Q1 25
$2.3B
$783.9M
Q4 24
$783.4M
Q3 24
$833.3M
Q2 24
$892.8M
Q1 24
$855.9M
Debt / Equity
CRI
CRI
PIII
PIII
Q4 25
Q3 25
Q2 25
4.09×
Q1 25
2.71×
Q4 24
1.43×
Q3 24
1.11×
Q2 24
0.80×
Q1 24
0.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRI
CRI
PIII
PIII
Operating Cash FlowLast quarter
$-128.0M
$-25.7M
Free Cash FlowOCF − Capex
$-144.1M
FCF MarginFCF / Revenue
-19.0%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
-11.04×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRI
CRI
PIII
PIII
Q4 25
$-25.7M
Q3 25
$-128.0M
$-15.4M
Q2 25
$40.3M
$-16.6M
Q1 25
$-48.6M
$-33.5M
Q4 24
$-57.2M
Q3 24
$-22.6M
Q2 24
$-10.2M
Q1 24
$-20.0M
Free Cash Flow
CRI
CRI
PIII
PIII
Q4 25
Q3 25
$-144.1M
Q2 25
$24.1M
Q1 25
$-59.0M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
CRI
CRI
PIII
PIII
Q4 25
Q3 25
-19.0%
Q2 25
4.1%
Q1 25
-9.4%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
CRI
CRI
PIII
PIII
Q4 25
Q3 25
2.1%
Q2 25
2.8%
Q1 25
1.6%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
CRI
CRI
PIII
PIII
Q4 25
Q3 25
-11.04×
Q2 25
90.37×
Q1 25
-3.13×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRI
CRI

Sales Channel Directly To Consumer$362.3M48%
Sales Channel Through Intermediary$283.8M37%
Other$110.4M15%
Gift Cards$1.3M0%

PIII
PIII

Capitated Revenue$366.2M95%
Health Care Patient Service$18.6M5%
Health Care Care Coordination Management Fees$2.7M1%

Related Comparisons